UrgoStart Contact


UrgoStart Contact is a non-adhesive, non-occlusive TLC-NOSF lipido-colloid matrix that does not stick to the wound, an innovative technology developed by Laboratoires Urgo.

Leg ulcers, diabetic foot ulcers and pressure ulcers take an average of 210 days* to heal.(1)

 

*CNAM database: leg ulcers: 210 days; pressure ulcers: 223 days; diabetic foot ulcers: comparative data not available.

 

UrgoStart Contact is a local treatment that reduces the healing time of these types of wounds by an average of 100 days.(5)

UrgoTul

 

UrgoTul is produced using Lipido-Colloid Technology, an exclusive patented innovation from Laboratoires Urgo.

UrgoTul is a non-adhesive, non-occlusive interface, composed of a polyester mesh impregnated with hydrocolloid particles (carboxymethylcellulose), paraffin oil, petrolatum and polymers.

 

 

 

UrgoStart

UrgoStart is an absorbent hydrocellular lipido-colloid dressing with a micro-adherent TLC-NOSF matrix, an innovative technology developed by Laboratoires Urgo.

Leg ulcers, diabetic foot ulcers and pressure ulcers take an average of 210 days* to heal.(1)

*CNAM database: leg ulcers: 210 days; pressure ulcers: 223 days; diabetic foot ulcers: comparative data not available.

 

UrgoStart is a local treatment that reduces the healing time of these types of wounds by an average of 100 days.(5)

UrgoClean

UrgoClean, for complete and continuous cleansing

UrgoClean cleanses the wound of debris that impairs the healing process

 

UrgoK2

UrgoK2/ UrgoK2 Latex Free is a multitype two-layer compression system composed of a short-stretch bandage and a long-stretch bandage. Its exclusive PresSure system technology, based on pressure indicators on both bandages, facilitates application of the recommended therapeutic pressure level of around 40 mmHg from the very first application.

 

 

 

Who we are

Urgo Medical, a family company Urgo Medical is the advanced wound care division of the French family-group Urgo. Our mission: healing people As wounds are a source of suffering around the world, our mission, as the Healing Company, is to support healthcare professionals heal people with evidence-based treatments & innovative services so that life can …

UrgoTul Ag

UrgoTul Ag è una medicazione non-aderente in poliestere conformabile con matrice all’argento TLC-Ag per combattere l’infezione locale.

 

 

Urgo Medical in the Middle East

With several years of experience in the Middle East, Urgo Laboratories has chosen to accelerate its presence in this region through key partnerships with local distributors specialized in wound care. Our activity is focusing on the management of patients suffering from chronic and acute wounds, piloted in Dubai. It enables us to cover main countries …

Join us

The Urgo Medical corporate culture as seen by Laurent Faugère, the company’s CEO “On joining Urgo Medical, you will meet many different teams who are united by a common mission, “Healing People”, support healthcare professionals heal people by providing evidence-based treatments & innovative services so that life can start again for patients. This mission guides …

UrgoStart Plus Border

Leg ulcers, diabetic foot ulcers and pressure ulcers take an average of 210 days to heal.(1)

UrgoStart Plus Border is a local treatment that is effective at every wound phase to reduce healing time by an average of 100 days.(4)